What is a chylothorax?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Chylothorax?

A chylothorax is the accumulation of chyle (lymphatic fluid) in the pleural space resulting from disruption of the thoracic duct or its tributaries. 1

Definition and Pathophysiology

  • Chyle is lymphatic fluid primarily formed in the intestines, composed of proteins, lipids, electrolytes, and lymphocytes. 2
  • The hallmark feature is the presence of chylomicrons in the pleural fluid, giving it a characteristic milky, opalescent appearance (though appearance can vary based on nutritional status). 2
  • The fluid is odorless, alkaline, and sterile. 2
  • Chylothorax typically appears on the right side since most of the thoracic duct is within the right hemithorax; damage at the level of the aorta causes left-sided effusions. 3

Diagnostic Criteria

When chylothorax is suspected, pleural fluid should be sent for measurement of triglyceride and cholesterol levels, with laboratory evaluation for cholesterol crystals and chylomicrons. 1

Objective diagnostic criteria include:

  • Pleural fluid triglyceride level >110 mg/dL (>1.24 mmol/L) 2, 4
  • Ratio of pleural fluid to serum triglyceride level >1.0 2, 4
  • Presence of chylomicrons (confirmed by lipoprotein electrophoresis) 2, 5
  • Triglyceride <50 mg/dL (<0.56 mmol/L) essentially excludes chylothorax 1

Etiologies

Traumatic Causes (54% of cases):

  • Iatrogenic injury is most common, including esophageal resections, lung cancer resections, cardiovascular surgeries, and spinal surgeries. 4
  • Accidental trauma to the thoracic duct. 3

Non-traumatic Causes (46% of cases):

  • Malignancy accounts for approximately 50% of all chylothorax cases, with lymphoma being the most common (75% of malignant chylothoraces). 1, 4
  • Other non-malignant causes include lymphangioleiomyomatosis, sarcoidosis, tuberculosis, amyloidosis, cirrhosis, heart failure, nephrotic syndrome, and venous thrombosis. 1, 4

Critical Distinction: Chylothorax vs. Pseudochylothorax

Chylothorax must be distinguished from pseudochylothorax ("cholesterol pleurisy"), which results from cholesterol crystal accumulation in long-standing pleural effusions with markedly thickened, fibrotic pleura. 1

Key differentiating features:

  • Pseudochylothorax: cholesterol level >200 mg/dL (>5.18 mmol/L), no chylomicrons, cholesterol crystals present on microscopy. 1
  • Chylothorax: high triglycerides, chylomicrons present, no cholesterol crystals. 1
  • Chronic rheumatoid pleurisy is now the most common cause of pseudochylothorax (historically tuberculosis). 1

Common pitfall:

  • Milky empyema can mimic chylothorax but can be distinguished by bench centrifugation, which leaves a clear supernatant in empyema as cell debris separates, while chylous effusion remains milky. 1

Clinical Significance

  • The lymphocyte-rich composition contributes to risk of immunosuppression in chronic chyle leak. 2
  • The high protein content explains the risk of malnutrition with ongoing losses, as repeated drainage causes loss of fat, proteins, and lymphocytes. 2, 3
  • Chylothorax can lead to significant morbidity and mortality if not properly managed. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Composition of Chylothorax Fluid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chylothorax and pseudochylothorax.

The European respiratory journal, 1997

Guideline

Causes and Diagnosis of Chylothorax

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chylothorax in thoracic oncology: diagnostic challenges and management strategies.

Medical oncology (Northwood, London, England), 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.